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Antibody-specified B-cell epitope prediction in
line with the principle of context-awareness
Liang Zhao Limsoon Wong Jinyan Li*
Abstract—Context-awareness is a characteristic in the recognition between antigens and antibodies, highlighting the reconfiguration
of epitope residues when an antigen interacts with a different antibody. A coarse binary classification of antigen regions into epitopes, or
non-epitopes without specifying antibodies may not accurately reflect this biological reality. Therefore, we study an antibody-specified
epitope prediction problem in line with this principle. This problem is new and challenging as we pinpoint a subset of the antigenic
residues from an antigen when it binds to a specific antibody. We introduce two kinds of associations of the contextual awareness:
(i) residues-residues pairing preference, and (ii) the dependence between sets of contact residue pairs. Preference plays a bridging
role to link interacting paratope and epitope residues while dependence is used to extend the association from one-dimension to two-
dimension. The paratope/epitope residues’ relative composition, cooperativity ratios, and Markov properties are also utilized to enhance
our method. A non-redundant data set containing 80 antibody-antigen complexes is compiled and used in the evaluation. The results
show that our method yields a good performance on antibody-specified epitope prediction. On the traditional antibody-ignored epitope
prediction problem, a simplified version of our method can produce a competitive, sometimes much better performance, in comparison
with three structure-based predictors.
Index Terms—Epitope prediction, context dependence, antibody, antigen.
F
1 INTRODUCTION
A B-cell epitope is a small subset of residues in anantigen sequence which can be recognized by a
specific antibody [1]. Epitopes can be categorized into
two types: continuous and discontinuous [2]. A contin-
uous epitope consists of residues that are contiguous
in the primary antigen sequence, while a discontinuous
epitope is formed by residues that are separated, some-
times far away, from each other in the primary sequence
but they are close to each other in 3D space through
polypeptide folding. For example, the epitope in the
antigen chain E of PDB:1ZTX is constituted by five dis-
tant stretches: TYR302, SER306 LYS307 ALA308 PHE309,
THR330 GLY331 THR332 ASP333, ALA365 THR366
ALA367 ASN368, and GLY389 GLU390 GLN391. All
these short segments are required for the recognition by
the antibody and thus they are not five epitopes on their
own. Due to the importance of identifying epitopes in
vaccine design, disease diagnosis and disease therapy
[3], intensive efforts have been made to predict both
continuous and discontinuous epitopes over the past few
decades.
Context-awareness in the recognition between anti-
gens and antibodies [4], [5], also known as context de-
pendence, is the key idea that motivates the whole work
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in this paper. Context-awareness is a property high-
lighting that epitope is a dependent entity—An epitope
cannot be formed without a corresponding antibody [5].
Therefore, epitope can be detected only at the point
when an antigen interacts with a specific antibody area
which is called the paratope of the antibody. A more
intriguing facet of such binding mechanism is that the
cluster of residues that acts as an epitope under one set
of circumstances will not necessarily behave as epitope
under another set [5]. In other words, an epitope of
an antigen may be reconfigured with a different set of
residues when a different antibody is presented in the
interaction. For instance, the epitope of the prior protein
as shown in PDB:1TQB consists of residues GLY127,
LEU128, ASN156, TYR158, ARG159, ILE185, LYS188,
GLN189, THR191, VAL192, THR193, THR194, THR195,
THR196, LYS197, GLY198 and GLU199. However, the
epitope of this antigen is reconfigured remarkably when
the antibody is changed to another protein as shown in
PDB:2W9E. The reconfigured epitope consists of residues
GLY145, SER146, ASP147, TYR148, ASP150, ARG151,
TYR152, ARG154, GLU155, ASN156, HIS158, ARG159,
ASN200, THR202 and LYS207, having only two common
residues (ASN156 and ARG159) overlapping with the
first epitope. Therefore, a coarse binary classification of
antigen regions into epitopes, or non-epitopes without
specifying antibodies and paratopes may not accurately
reflect biological reality [5].
The aim of this work is to predict the location of
the epitope residues when we are given the sequence
of an antigen and the heavy chain and light chain
sequence of an antibody. Existing methods [6], [7], [8],
[9], [10], [11], [12] generally overlooked the property
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of context-awareness, and studied instead an antibody-
ignored B cell epitope prediction problem. Given an
antigen, these earlier methods just tell the union of all
antigenic residues in this antigen. They were unable to
specify which subset of the antigenic residues that can
form an epitope binding to an antibody.
In light of this context-awareness, we introduce two
kinds of associations: (i) the residues-residues pairing
preference between epitopes and paratopes, and (ii)
the dependence between two sets of contact residue
pairs. Both of them are mined from antibody-antigen
complexes for the training of our model. When an
antigen-antibody complex without structural informa-
tion is presented for epitope prediction, the preference
association plays a bridging role to link the residues
from the paratope to the epitope, and the dependence
association is used to infer new set of contact paratope-
epitope residue pairs. Our prediction begins by identi-
fying antibody paratope residues. This idea is based on
the fact that antibody paratopes are regularly structured
and are easy to be identified. The residues of a paratope
are usually located in six complementary determining
regions (CDRs), namely L1, L2, L3, H1, H2 and H3 [13].
The first three CDRs are in antibody light chain, and
the other three are in antibody heavy chain. The six
CDRs can be identified by the Chothia CDR definition
[14], and the paratope residues can be easily located
by the residues’ relative composition and cooperativity
information. Figure 1 shows a diagram of our prediction
method and illustrates how the preference association is
used to predict epitope residues and how a dependence
association is used to infer a new set of contact residue
pairs. As there are still possibly many uncertain residues
in the antigen, a semi-supervised Hidden Markov Model
(HMM) is proposed to complete the process of epitope
prediction.
Our technical ideas differ from traditional ones. Very
often, physico-chemical properties, such as individ-
ual amino acid’s hydrophilicity, backbone flexibility,
residue’s antigenic propensity, exposed surface area and
so on, were used to tackle the problem of predicting
continuous epitopes [6], [7], [8], [9]. Single or combina-
tions of different properties including solvent-accessible
surface area, spatial information, contact distance and
amino acid statistics had been also proposed as features
to study the discontinuous epitope prediction problem
[10], [11], [12]. Some advanced machine learning ap-
proaches were also exploited [15], [16], [17], [18], [19].
Overall, the performance on the traditional antibody-
ignored epitope prediction problem was not satisfactory
for either continuous or discontinuous epitopes [20], [21],
[22].
We name our method ABepar short for Antibody-
specified B-cell epitope prediction through association
rules. As mentioned, our method is trained on
antibody-antigen PDB complexes, but it can be ap-
plied to any antibody-antigen sequence pairs that do
not contain structural information. By simplifying the
Fig. 1. Antibody-specified epitope identification by
using associations and a semi-supervised Hidden
Markov Model. Here, the unfilled circles represent non-
paratope/epitope residues. The paratope residues are
colored by orange, and the epitope residues are colored
by light green and purple. We distinguish them by light
green and purple because the light green circles are the
epitope residues that interact with this specific antibody,
while the purple circles are in a different epitope that
interacts with another antibody when the environment
changes. The solid arrows represent our epitope identi-
fication by the preference between paratope and epitope
residues, while the dashed arrow and two boxes repre-
sent our epitope detection through dependence within two
sets of paratope-epitope interacting residue pairs. The
circles colored by green are the epitope residues that
we can identify. The purple residues are not predicted as
restricted by the context awareness.
computational steps, our ABepar method can also
be used to conduct the traditional epitope predic-
tion when only antigen sequence is provided. The
software and supplementary data are available at
http://155.69.2.25/~s080011/index.html
2 MATERIALS AND METHODS
2.1 Data set
We compiled a set of 80 non-redundant X-ray crystallo-
graphic antigen-antibody complexes with the resolution
better than 3.0A˚ after an exhaustive search from PDB
[23]. Each complex in this data set satisfies: (i) it contains
three or more polypeptides each with a length  30
amino acids; (ii) it contains antibody variable regions,
such as Fab, VHH or Fv fragments; and (iii) the paratope
residues of each complex are mainly situated in the six
CDRs. Besides, if a structure contains more than one
asymmetric units but with no structural difference, only
one unit is selected. To remove redundancy, an antigen
structural pair-wise alignment was carried out by the
combinatorial extension (CE) algorithm [24]. An antigen
is redundant if the following criteria are met: (i) The
alignment z-score is  4.0; (ii) The root mean square
deviation (RMSD) of the alignment is  3A˚; (iii) The
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proportion of the matching residues against the aligned
positions is  80%; (iv) The proportion of overlapping
epitope residues is  80% against the epitope residues
of the shorter sequence. The first criterion is based on
the CE algorithm, while the middle two are suggested
by [21].
2.2 Construction of our training model
Given an antibody-antigen PDB complex, the epitope
and paratope residues are determined by using a dis-
tance threshold 4A˚. (This threshold was recommended
by [11] as it can capture the epitopes and paratopes with
a high precision.) One residue is considered as an epitope
residue if there exists an atom of this residue, except
hydrogen, that is separated within a distance of 4A˚ from
an atom of an antibody residue except hydrogen. This
antibody residue is correspondingly called a paratope
residue.
Taking all of the epitopes and paratopes from the
training data, we mine the residues-residues pairing
preference in these binding sites, as well as the depen-
dency between sets of contact residue pairs. We also
compute residue’s relative composition and coopera-
tivity values. These compositions and associations are
then subsequently used when a pair of antibody-antigen
sequences is given for epitope prediction. The detailed
flowchart of training and testing is shown in Figure 2.
The upper part of the flow chart shows our steps in
model construction and the lower part depicts the steps
for epitope prediction.
2.2.1 Associations: residues-residues pairing prefer-
ence and dependence between two sets of contact
residue pairs
A residues-residues pairing preference in paratope-
epitope interacting complex is defined as a frequent
biclique G = hVb; Vg; Ei, where Vb is a set of vertices
representing paratope residues, and Vg is a set of vertices
representing epitope residues. E is a set of edges consti-
tuted by paratope-epitope contact residue pairs, satisfy-
ing the condition jEj = jVbj  jVgj, i.e. 8vb 2 Vb;8vg 2 Vg ,
hvb; vgi 2 E. This concept of residue pairing preference
underlies the pairing or full interaction between a group
of paratope residues and a group of epitope residues.
It extends the common pairing between two single
residues, and it can expand the statistical and biological
significance of residue pairing as demonstrated in our
early work [25] where protein binding hotspots are
studied.
Residues-residues pairing preferences are identified
from a set of antibody-antigen PDB complexes through
the following steps: (i) Determine all paratope and
epitope residues of each antibody-antigen complex by
using the distance threshold 4A˚; (ii) Construct a bipartite
graph from the paratope-epitope interacting residue
pairs of each complex. The vertices are the paratope and
epitope residues, and the edges stand for the contacts
between paratope and epitope residues; (iii) Identify
the maximal bicliques from every bipartite graph by
using the LCM-MBC algorithm [26]; and (iv) select
the frequent bicliques from all the antibody-antigen
complexes with a minimum occurrence level of 7%.
A dependence between two sets of interacting residue
pairs is described by an association rule. It highlights
the extent to which one set of interacting residue pairs
is dependent on the other set. In other words, if one set
of interacting residue pairs is observed in a binding site,
then what is the probability that (at which confidence
level) the residue pairs in the other set also occur in this
binding site. Formally, such an association rule is in the
form fhpo1-eo1i; hpo2-eo2i; : : :g ! fhpi1-ei1i; : : :g , where hp-ei
represents a contact residue pair in the paratope-epitope
binding site. The superscript omeans observed paratope-
epitope interacting residue pair, while the superscript i
means the implied interaction.
Four steps are taken in detecting contact residue pair
dependence from a set of antibody-antigen interacting
complexes. (i) Identify all the paratope-epitope interact-
ing residue pairs of each complex by using the distance
threshold 4A˚; (ii) Transform each interacting residue pair
hp-ei into an item Ip;e by using Ip;e = Ip  20+ Ie, where
Ip is the index of residue p, and Ie is the index of residue
e. A residue index is the position number of this residue
in the Kyte and Doolittle’s increasing hydropathy index
[27]; (iii) Form a transaction for each binding site of one
complex with the transformed items; and (iv) Mine all
frequent association rules from this transactional data
set by an association rule mining software developed by
[28]. The support and confidence level were set as 7%
and 80% respectively during the dependence mining.
2.2.2 Residue’s relative composition and cooperativity
Paratope residue’s relative composition is defined as
RCij = P
i
j  2  log2(P ij=Qij), where RCij is the relative
composition of residue j in CDR i, P ij is the composition
of residue j over the paratope residues in CDR i, and Qij
represents the composition of residue j over all residues
in CDR i. Epitope residue’s relative composition is com-
puted similarly, defined as RCj = Pj  2  log2(Pj=Qj),
where RCj is the relative composition of residue j, Pj is
the composition of residue j over the epitope residues,
and Qj represents the composition of residue j over all
antigen residues.
Regarding paratope residue’s cooperativity, it is de-







cooperativity of residue pair jk with respect to CDR
i, P ijk is the composition of residue pair jk over the
paratope residues in CDR i, and Qijk is the compo-
sition of residue pair jk over all residues in CDR i.
Epitope residues’ cooperativity is calculated similarly by
COjk = (Pjk=Qjk), where COjk is the cooperativity of
residue pair jk within antigens, Pjk is the composition of
residue pair jk over the epitope residues and Qjk is the
composition of residue pair jk over all antigen residues.
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Fig. 2. Flow chart of model construction and epitope prediction.
Here residue pair specifies the paired neighborhood
residues.
2.3 Sequence-based epitope prediction
Using the model components constructed from the train-
ing data of antibody-antigen PDB complexes as de-
scribed in the above subsection, the epitope in a given
antigen sequence can be predicted through the following
steps when an antibody sequence is also given:
 Identifying seed paratope residues by using the
paratope residues’ relative composition;
 Detecting neighborhood paratope residues of the
seeds by using the paratope residues’ cooperativity
ratios;
 Specifying candidate epitope residues by using the
paratope-epitope interacting preference;
 Inferring new sets of paratope-epitope interacting
residue pairs from the observed contact residue
pairs by dependence;
 Seeding epitope residues from the candidate epitope
residues by utilizing the epitope residues’ relative
composition;
 Screening out neighborhood residues of the seeds
by using the epitope residues’ cooperativity ratios;
 Completing epitope identification by using a semi-
supervised Hidden Markov Model.
2.3.1 Identifying seed paratope residues
Given an antibody-antigen complex without structure in-
formation, the antibody heavy chain and light chain are
numbered by the modified-Chothia numbering scheme
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[29], then the six segments of CDRs are determined
according to the Chothia CDR definition [14].
Every residue within the six CDRs is tested against a
CDR-dependent paratope residue’s relative composition
threshold. Residues that meet the constraint are marked
as seed paratope residues. Empirically, the thresholds are
set to allow only the top three types of residues to pass
the test.
2.3.2 Detecting neighborhood paratope residues of the
seeds
Having identified the seed paratope residues, the neigh-
borhood paratope residues of these seeds can be
screened out by using the paratope residues’ cooperativ-
ity ratios. More exactly, if a residue i has been marked
as a paratope residue, then the cooperativity between
its left neighbor i-1 and itself is tested against a CDR
dependent threshold Tco. The left neighbor residue i-1 is
marked as a paratope residue if and only if COi 1;i 
Tco. This test is also applied to the right neighbor of i.
Both the left and right neighbors are required to be in the
same CDR as i’s. Usually, the threshold is set to be such
a proper number that only the top ten percent coopera-
tivity ratios of the pair-wise neighborhood residues can
pass the test.
2.3.3 Specifying candidate epitope residues by prefer-
ence
A subset of paratope residues can be picked out from
the first two steps, then the candidate epitope residues
that could interact with these paratope residues are de-
termined by residues-residues pairing preference which
plays a subtle bridging role in linking paratope residues
to epitope residues. To achieve this goal, all paratope
residues of V
0






checked against the already identified paratope residues,
and then the epitope residues V
0
g in this pattern are




2.3.4 Inferring new sets of contact residue pairs by
dependence
Based on the paratope-epitope interacting residue pairs
specified by preference, new sets of paratope-epitope
contact residue pairs can be implicated by dependence.
For each dependence pattern fhpo1-eo1i; : : : ; hpom-
eomig!fhpi1-ei1i; : : : ; hpin-einig, all the interacting pairs
hpoi -eoi i from the observed set are checked against
the identified interacting residue pairs. The implied
interacting residue pairs hpi-eii are considered as true
interaction in this antibody-antigen binding site if all of
the observed pairs hpo-eoi have been identified by the
preference associations.
Preference combines paratope and epitope together,
while dependence implicates new interactions between
the paratope and epitope from the interactions produced
by preference, and in return the result generated by
dependence can provide new clues for preference. This
reciprocal enhancement works well in identifying inter-
actions between an antibody and an antigen. These two
steps and the neighborhood residue detecting step are
terminated until no more paratope/epitope residues can
be identified from a given antibody-antigen sequence
pair.
2.3.5 Seeding epitope residues
The seed epitope residues are identified through a simi-
lar strategy as seed paratope residues identification with
only a slight difference. First, when determining the seed
epitope residues, both epitope residues’ relative compo-
sition and the candidate residues are considered. More
exactly, a residue from the antigen sequence is marked as
an epitope residue if and only if its relative composition
exceeds the preset threshold T ehrc and this type of amino
acid has already been fished out by the paratope-epitope
associations (preference and dependence). Second, due
to that the whole antigen sequence could be antigenic,
the residues are checked one-by-one along the whole
antigen sequence. Third, besides identifying the seed
epitope residues, those residues with very low RC val-
ues with respect to a threshold T elrc are marked as non-
epitope residues. Empirically, only the best four and the
worst three types of residues can pass through these two
thresholds respectively.
2.3.6 Screening out neighborhood epitope residues
Neighborhood epitope residues are detected by using
exactly the same strategy of neighborhood paratope
residue detection. One more thing is to screen out the
non-epitope residues based on the non-epitope seeds.
A neighborhood residue is marked as a non-epitope
residue if the cooperativity between this neighbor and
itself is within the lowest ten percent of all the ob-
served cooperative residue pairs according to the epitope
residues’ cooperativity ratios.
2.3.7 Completing epitope identification
A stringent threshold based epitope identification strat-
egy can identify a subset of epitope residues and non-
epitope residues with high accuracy, but leaves a large
number of antigen residues still hidden. Thus we intro-
duce a semi-supervised Hidden Markov Model (HMM)
to complete the prediction of epitope residues.
An HMM is a statistical Markov model with unob-
served states  and observed variables X . In our case,
the unobserved states are epitope and non-epitope, and
the observed variables are the twenty standard amino
acids. Figure 3 illustrates the diagram of the first-order
hidden Markov model for epitope prediction which
is quantified by parameters of transition probability
and emission probability. The transition probability and
emission probability are calculated by equation (1) and
equation (2), respectively
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Fig. 3. First order hidden Markov model for epitope
prediction. Arrows represent transition, and the numbers
on arrows stand for transition probability from one state to
another. Representative emission probabilities for state N











where Ak;l is the number of transitions from state k
to state l,  is a set of states, Bk() is the number of
emitting symbol  at state k, and 
 is a set of symbols
standing for the set of twenty standard amino acids.
In this work, the first-order HMM and second-
order HMM are utilized together to build
a better classifier. For the first-order HMM,
 = fbegin;N;E; endg, and for the second-order
HMM  = fbegin;NN;NE;EN;EE; endg. The symbol
N represents the state of non-epitope residue, while E
represents the state of epitope residue.
For a given sequence of antigen residues x =
(x1; x2;    ; xm), the most probable sequence of states
(or say labels)  = (1 ; 2 ;    ; m) is estimated by the
Viterbi algorithm [30]. Suppose k(i), which is calculated
by equation (3), is the maximal probability of the path
ending at sequence position i with state of k when
observation is known, then the induction of l(i + 1)
is carried out by equation (4). After determining the
maximal probability for each site, then the most likely
state for each site is determined by equation (5) if the
state of site i has not been determined yet. If the state
of site i has already been determined by the epitope
seeding and neighborhood epitope residue screening,
then it keeps the state unchangeable. We employ this
semi-supervised learning method because of the signif-
icantly uneven distributed transition probability from
non-epitope residue to epitope residue.
k(i) = max
1;:::;i 1
P (1; : : : ; i 1; i = k; x1; : : : ; xi) (3)
l(i+ 1) = bl(xi+1)max
k











3.1 Residues’ relative composition and cooperativ-
ity in paratope and epitope
The paratope and epitope residues’ relative composi-
tions show that the same type of residue has diverse
tendencies in antigen binding. Residue Y has a very
high probability to become a paratope residue in CDR
L1 and L2, while this tendency is weakened in other
CDRs; residue D favors all the CDRs except H3 which
is exactly a reverse tendency for residue G. Intriguingly,
the same residue has very different relative composition
in the six CDRs and antigen (the paratopes and epitopes
comment: we intend to illustrate the diverse profiles of
the same residue in six CDRs and antigen, but not the
difference between different paratopes and epitopes). For
example, residues Q, H and P are more likely to be
epitope residues rather than paratope residues, while
residues N, Y, W and S are in favor of paratope residues
instead of epitope residues, in particular for residues
Y and W. Our this finding on residues Y and W does
not agree very well with the result reported by [31].
The reason should be that Y and W are rich in antigen
sequence although they have a relatively large propor-
tion in epitopes. In addition, our results clearly illustrate
that epitopes prefer very much hydrophilic residues to
hydrophobic residues. Detailed information is presented
in supplementary Figure S1 and S2,
Our findings suggest that each CDR makes differ-
ent contribution in antigen binding and that the same
residue can exhibit diverse roles and profiles in six CDRs
and antigen (epitopes). This confirms our idea of treating
the six CDRs separately. The proportion of each CDR’s
contribution in antigen binding is presented in Table
1. The value is calculated based on the count of each
paratope residue that interacts with epitope residues.
For example, if one paratope residue interacts with two
epitope residues then its contribution is counted twice
instead of once. By this definition, H3 makes the highest
contribution in antigen binding and L2 presents the
lowest. Besides, the three CDRs from the antibody heavy
chain take about two thirds contribution in antigen
binding. Although a different and simple definition of
calculating contribution is used here, our observations
are consistent with the findings reported in [32].
The cooperativity ratios of epitope residue pairs and
those in the paratope residue pairs in CDR H3 which
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TABLE 1
Proportion of each CDR’s contribution in antigen binding
CDR L1 L2 L3 H1 H2 H3
Proportion 0.121 0.066 0.161 0.130 0.187 0.336
contributes about one third in the antigen binding are
shown in supplementary Figure S3. The high values
at the top-left corner of the epitope cooperativity pic-
ture emphasize that epitope residues prefer pairs of
hydrophilic residues. With regard to the residue pairs
within CDR H3, unexpectedly they cover only a few
residues, e.g. Y, W, S, T and G. Although hydrophobic
residues are scarce in the paratopes, they tend to coop-
erate with other residues once they occur in a paratope.
This is interesting.
3.2 Associations in paratope-epitope interacting
pairs
The key idea of this work is to use two kinds of as-
sociations, the preference and dependence, to address
the problem of antibody-specified epitope prediction.
As introduced, preference can reflect the contextual
relation between paratope and epitope residues in a
local manner, while dependence can span this contextual
relation between two local sub-regions. The combina-
tion of these two rules, which extends association from
one-dimension to two-dimension, can well capture the
concept of context-awareness in the recognition between
paratopes and epitopes.
The residues-residues pairing preferences with fre-
quency (or, support)  12% are shown in Table 2. As
an example, the second preference in Table 2 means that
paratope residues fD,Yg interact frequently (15 out of
80) with epitope residue K. Overall, these most frequent
paratope preference residues are enriched by Y, D, S
and G, while the epitope residues are rich of K, R, Q
and E. This observation applauds the findings given by
residues’ relative composition in another way. Interest-
ingly, residue G does not have a very high relative com-
position, however G is rich in H3 which takes about one
third contribution in antigen binding. Therefore residue
G is also frequent in paratope. We take another example
of preference to illustrate how the preference information
is used in epitope prediction. Using hfG,YgSfEgi, we
can say that once residues G and Y have been identified
as paratope residues, then residue E can be marked as a
candidate epitope residue.
The dependencies with support level  10% and
confidence level  90% are listed in Table 3. Taking
fhD-Ki,hW-Kig!fhY-Kig as an example to demonstrate
the usefulness of dependence, we can say that once
paratope-epitope interacting residue pairs hD-Ki and
hW-Ki are predicted or observed in the binding site, then
hY-Ki is believed to occur in this site as well with 100%
confidence. Compared with preference shown in Table 2,
TABLE 2
Preference between paratope residues and epitope
residues with frequency (or, support)  12%.
Paratope(s) Epitope(s) Frequency Redundancy
D K 21.3%(17/80) 1.24(21/17)
D,Y K 18.8%(15/80) 1.27(19/15)
S E 16.3%(13/80) 1.15(15/13)
D R 13.8%(11/80) 1.18(13/11)
D,Y R 12.5%(10/80) 1.70(17/10)
G,Y E 12.5%(10/80) 1.40(14/10)
S K 12.5%(10/80) 1.00(10/10)
one can see that dependence involves a much broader in-
teractions between paratope and epitope residues. Thus
the reciprocal enhancement between these two associa-
tions facilitates the accurate antibody-specified epitope
identification.
TABLE 3
Dependence in paratope-epitope interacting residue
pairs with support  10% and confidence  90%
Obs. Pair(s)j Imp. Pair(s)! confidence
hD-Ki, hW-Ki hY-Ki 100.0%
hT-Ki hY-Ki 100.0%
hY-Gi, hT-Ki hY-Ki 100.0%
hD-Ki, hT-Ki hY-Ki 100.0%
hW-Ki hY-Ki 93.33%
hY-Gi, hS-Ei hY-Ei 90.00%
hN-Gi hY-Gi 90.00%
j: Observed paratope-epitope interacting pairs;
!: Implied paratope-epitope interacting pairs.
An example of the two-dimensional associations be-
tween an antigen and its antibody’s six CDRs (in
PDB:1EGJ) are partially shown in Figure 4. The pre-
diction of the epitope residues is proceeded as follows:
(i) residues TYR:32:H, TYR:30B:L, ASN:91:L, ASN:92:L,
TRP:96:L are fished out in the step of identifying
seed paratope residues, (ii) residue GLU:93:L is se-
lected by using cooperativity detection, and (iii) epi-
tope residues R, K and E are identified by utilizing
these paratope information, residue’s relative composi-
tion and the paratope-epitope association patterns, such
as hfNgSfRgi, hfYgSfEgi, and fhY-Ri, hY-Eig!fhY-Kig.
Other epitope residues within this antigen sequence are
identified by using the same strategy. To complete the
identification, a semi-supervised HMM is used in the
final step to label the undetermined residues.
3.3 Performance of ABepar for antibody-specified
B-cell epitope prediction
Leave-one-out cross validation is carried out to evalu-
ate the performance of our method. In every iteration,
one complex without its structural information is tested
against the model constructed by using the rest 79 PDB
complexes in the training. Four metrics are adopted to
quantify the performance which are sensitivity (sen.),
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Fig. 4. Associations between the paratope and epitope
residues within PDB:1EGJ. The epitope residues are
rendered by red spheres, while the other antigen residues
are colored by green. (Only a small segment of the anti-
gen sequence is shown here.) The paratope residues are
colored by yellow and orange for the antibody heavy and
light chain respectively, meanwhile other residues within
six CDRs are rendered by their surface. The dashed blue
lines are used to illustrate the preference between the
paratope and epitope residues. This picture is generated
by PyMol [33].
specificity (spe.), accuracy (acc.) and F-measure (F1).
Their definitions are given by: sen: = TP=(TP + FN),
spe: = (TN)=(TN+FP ), acc: = (TP +TN)=(TP +TN+
FP+FN), and F1 = 2(precisionrecall)=(precision+
recall), where TP is the number of correctly predicted
epitope residues, TN is the number of correctly predicted
non-epitope residues, FP is the number of incorrectly
predicted epitope residues which should be non-epitope
residues in reality, FN is the number of incorrectly
predicted non-epitope residues which should be epitope
residues in fact, precision is the proportion of correctly
predicted epitope residues with respect to the total
number of predicted epitope residues, and recall is the
proportion of correctly identified epitope residues with
respect to the total number of actual epitope residues.
The detailed performance on the 80 complexes are
reported in (the) Table 4. Figure 5 plots a visualization for
the performance of sensitivity versus specificity on all of
the 80 complexes. The average sensitivity is 0.4340.238,
the average specificity is 0.7810.126, and the overall
accuracy is 0.7490.103. We note that the distribution of
the non-epitope and epitope residues for every antigen is
extremely un-balanced with the ratio 12.6510.15 on av-
erage. This nature of imbalance increases the complexity
of the prediction problem and skews the competence of
accuracy. Thus the F1-scores are also presented in Table 4
(columns 9 and 18) for a more meaningful measurement.
To avoid inflated performance caused by the high sim-
ilarity between antigen sequences, we further analyzed
the antigen sequence similarity by using local pairwise
Fig. 5. Sensitivity versus specificity performance on the
80 complexes by ABepar.
sequence alignment with the BLOSUM62 substitution
matrix. The pairwise sequence’s (sequences) similarities
of all the 80 antigen sequences are shown in Figure 6. We
found that about 98.9% of the antigen sequence pairwise
similarities are less than or equal to 0.25. That is, there
is a faint over-fitting problem caused by the sequence
similarity and the results well reflect the capability of
our method. Although there are still a couple of antigen
sequences having a very high similarity, their epitopes
are quite different from each other. For instance, the
epitope residues of PDB:1A2Y are 19N, 22G, 23Y, 24S,
27N, 102G, 103N, 116K, 117G, 118T, 119D, 120V, 121Q,
124I and 125R, while the epitope residues of PDB:1J1O
are 15H, 16G, 19N, 20Y, 21R, 62W, 63W, 73R, 75L, 77N,
89T, 93N, 96K, 97K, 100S, 101D, 102G and 103N. Clearly
there are only three overlapping residues between these
two antigens, which are 19N, 102G and 103N. According
to the performance on PDB:1A2Y and PDB:1J1O shown
in Table 4, we can conclude that our method can well
distinguish the antibody-specified epitopes.
The performance comparison between our method
and those methods described by Ponomarenko and
Bourne [21] shows that our method outperforms others
according to the sensitivity and specificity values. Re-
garding the comparison with continuous epitope predic-
tors, we note that there is no direct comparison because
of the different problems addressed. We also note that
the comparison with the methods in [21] is indirect as
we are dealing with the new, antibody-specified epitope
prediction problem rather than the traditional antibody-
ignored epitope prediction problem. Therefore, a direct
comparison under the strictly same platform is presented
in the following subsection where a simplified version of
ABepar is taken in the comparison.
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TABLE 4
The performance for antibody-specified epitope prediction on 80 antibody-antigen complexes by ABepar
PDB ID Ab Ag #Etp1 #NEtp2 sen. spe. acc. F1 PDB ID Ab Ag #Etp #NEtp sen. spe. acc. F1
1A2Y B A C 15 114 0.600 0.711 0.698 0.316 1ZTX H L E 16 85 0.563 0.882 0.832 0.514
1AR1 C D B 15 237 0.600 0.865 0.849 0.321 2ADF H L A 15 174 0.000 0.960 0.884 0.000
1BGX H L T 35 793 0.371 0.808 0.790 0.130 2AEP H L A 19 369 0.474 0.767 0.753 0.158
1BJ1 H L W 16 78 0.438 0.923 0.840 0.483 2ARJ H L Q 18 97 0.222 0.866 0.765 0.229
1BQL H L Y 12 117 0.000 0.923 0.837 0.000 2B2X H L A 18 170 0.556 0.859 0.830 0.385
1EGJ H L A 11 90 0.909 0.733 0.752 0.444 2BDN H L A 16 52 0.688 0.731 0.721 0.537
1EO8 H L A 15 304 0.133 0.849 0.815 0.063 2CMR H L A 17 178 0.235 0.972 0.908 0.308
1EZV X Y E 17 168 0.412 0.798 0.762 0.241 2DD8 H L S 19 173 0.474 0.832 0.797 0.316
1FE8 H L A 19 167 0.263 0.85 0.790 0.204 2FD6 H L U 12 237 0.667 0.755 0.751 0.205
1FJ1 B A F 17 234 0.588 0.791 0.777 0.263 2H9G H L S 12 52 0.583 0.615 0.609 0.359
1FNS H L A 12 184 0.750 0.783 0.781 0.295 2J4W H L D 11 23 0.636 0.826 0.765 0.636
1FSK C B A 17 142 0.118 0.711 0.648 0.067 2J5L C B A 11 23 0.273 0.826 0.647 0.333
1H0D B A C 16 106 0.875 0.500 0.549 0.337 2J88 H L A 9 310 0.778 0.703 0.705 0.130
1IQD B A C 16 140 0.188 0.829 0.763 0.140 2JEL H L P 15 70 0.533 0.686 0.659 0.356
1J1O H L Y 18 111 0.444 0.739 0.698 0.291 2NR6 D C A 14 315 0.357 0.905 0.881 0.204
1JHL H L A 11 118 0.818 0.729 0.736 0.346 2NY7 H L G 22 268 0.500 0.840 0.814 0.289
1JPS H L T 19 181 0.579 0.867 0.840 0.407 2NYY D C A 20 1247 0.350 0.874 0.866 0.076
1JRH H L I 15 80 0.067 0.975 0.832 0.111 2Q8B H L A 18 274 0.500 0.723 0.709 0.175
1LK3 H L A 18 118 0.389 0.763 0.713 0.264 2QQK H L A 12 529 0.167 0.711 0.699 0.024
1N8Z B A C 16 565 0.000 0.894 0.869 0.000 2QQN H L A 12 142 0.500 0.718 0.701 0.207
1NCA H L N 20 369 0.250 0.780 0.753 0.094 2R56 H L A 21 138 0.381 0.703 0.660 0.229
1NFD H G D 12 227 0.833 0.784 0.787 0.282 2UZI H L R 18 148 0.722 0.561 0.578 0.271
1NMB H L N 19 369 0.421 0.751 0.735 0.134 2VXQ H L A 14 78 0.286 0.782 0.707 0.229
1NSN H L S 17 121 0.647 0.554 0.565 0.268 2VXS I M A 7 79 0.429 0.443 0.442 0.111
1OAZ H L A 17 98 0.235 0.867 0.774 0.235 2VXT H L I 17 139 0.412 0.806 0.763 0.275
1OB1 A B C 13 83 0.769 0.771 0.771 0.476 2W9E H L A 15 84 0.800 0.571 0.606 0.381
1ORS B A C 10 122 0.000 0.975 0.902 0.000 2ZCH H L P 16 221 0.563 0.855 0.835 0.316
1OSP H L O 20 231 0.400 0.827 0.793 0.235 3B2U H L A 17 178 0.412 0.787 0.754 0.226
1OTS C D A 9 435 0.000 0.945 0.926 0.000 3B9K L H B 19 98 0.368 0.837 0.761 0.333
1P2C E D F 16 113 0.750 0.690 0.698 0.381 3BN9 F E A 22 219 0.545 0.653 0.643 0.218
1R3J B A C 13 90 0.538 0.844 0.806 0.412 3CVH H L A 15 259 0.467 0.780 0.763 0.177
1RJL B A C 12 83 0.667 0.663 0.663 0.333 3D9A H L C 18 111 0.444 0.739 0.698 0.291
1SY6 H L A 11 157 0.727 0.631 0.637 0.208 3D85 B A C 16 117 0.000 0.915 0.805 0.000
1TQB B C A 17 85 0.706 0.506 0.539 0.338 3EOA H L I 14 165 0.429 0.909 0.872 0.343
1UJ3 B A C 18 187 0.556 0.818 0.795 0.323 3G04 B A C 23 205 0.435 0.854 0.811 0.317
1V7M H L V 16 129 0.563 0.775 0.752 0.333 3GBN H L B 12 161 0.000 0.770 0.717 0.000
1W72 H L A 14 260 0.429 0.846 0.825 0.200 3GI9 H L C 16 421 0.188 0.938 0.911 0.133
1WEJ H L F 11 93 0.636 0.333 0.365 0.175 3GRW H L A 33 173 0.515 0.671 0.646 0.318
1YJD H L C 14 104 0.357 0.894 0.831 0.333 3H42 H L B 22 470 0.182 0.855 0.825 0.085
1YYM R Q P 13 286 0.308 0.916 0.890 0.195 3HI6 H L A 22 158 0.455 0.665 0.639 0.235
1: number of epitope residues, and 2: number of non-epitope residues.
3.4 Simplifying ABepar for antibody-ignored B-cell
epitope prediction
To our best knowledge, all previous methods for B-cell
epitope prediction do not use the context-dependence
principle in the recognition between antigens and anti-
bodies. Antigen is the only issue and data that is taken
for the prediction. Given an antigen, the prediction just
tells whether a residue is antigenic or not. The prediction
result is an unordered union of the antigenic residues of
the different epitopes that are formed when this antigen
interacts with different antibodies. Such an approach
can narrow down from the whole antigen sequence to
the smaller antigenic region, but it cannot pinpoint the
constituent residues of a specific epitope which is usually
much shorter than the antigenic region of an antigen.
An example is shown later. Therefore, such a generic
epitope prediction is quite different from the problem
we are addressing. To make a fair comparison between
our method and the previous ones, we compile a new
data set from PDB in which every antigen has multiple
antibody partners. The purpose of constructing such a
data set is aimed at alleviating the underestimation of
current epitope predictors caused by incomplete epitope
exploration [10], [11], [18]. This data set is shown in Table
5.
Three structure-based epitope prediction methods El-
liPro [12], DiscoTope [11], and SEPPA [34] are used in the
comparison. ElliPro predicts antigenic residues by means
of the protrusion index (PI) which is calculated based on
antigen structures. The performance here by ElliPro was
calculated over all the predicted discontinuous epitopes
with the default parameters. With regard to DiscoTope,
the epitope residues from a testing antigen structure is
predicted based on features that are extracted from a
set of training antigen structures, such as residue sol-
vent accessibility, residue spatial distribution and residue
propensity. The performance of DiscoTope was achieved
by using the default cutoff threshold -7.7. SEPPA iden-
tifies the antigenic residues by clustering the triangle
residues of unit patches, and the result shown here was
generated with the default parameter of 1.8.
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TABLE 5
Performance evaluation for ABepar, ElliPro, DiscoTope, and SEPPA on an epitope relatively completely explored data
set
antigen corresponding PDB ID #Aby F-measure
F1a F1e F1d F1s
1A2Y 1BQL 1BVK[C,F]z 1C08
44 0.747 0.683 0.519 0.722
1DQJ 1FDL 1G7H 1G7I 1G7J
1G7L 1G7M 1IC4 1IC5 1IC7
Hen egg 1J1O 1J1P 1J1X 1KIP 1KIQ
white 1KIR 1MLC[E,F] 1NDG 1NDM
lysozyme 1P2C[C,F] 1UA6 1UAC 1VFB
2DQC 2DQD 2DQE 2DQF[C,F]
2DQG 2DQH 2DQI 2DQJ 2EIZ
2EKS 2IFF 2YSS 3D9A
Vascular
6 0.464 0.571 0.540 0.567endothelial 1BJ1[V,W] 1CZ8[V,W] 2FJG[V,W]
growth factor
Ubiquitin 3DVG[X,Y] 3DVN[U,V,X,Y] 6 0.367 0.375 0.456 0.430
Influenza virus 1NCD 1A14 1NMB 1NCB 6 0.244 0.336 0.387 0.378neuraminidase 1NCC 1NCA
Von willebrand 1FE8[A,B,C] 2ADF 4 0.343 0.343 0.150 0.483factor
Outer surface 1FJ1[E,F] 1OSP 3 0.381 0.347 0.379 0.367protein A
Integrin alpha-L 3HI6[A,B] 3EOA[I,J] 4 0.385 0.381 0.386 0.479
Prion protein 1TPX 1TQB 1TQC 2W9E 4 0.630 0.355 0.526 0.480
Tissue factor 1JPS 1UJ3 2 0.426 0.00 0.241 0.195
a: ABepar, e: ElliPro, d: DiscoTope, and s: SEPPA.
y: number of antibodies interacting with this antigen. Some of the antibodies are mutants of its wild type.
z: multi-antigen chains in the same PDB complex.
: it is Bobwhite quail lysozyme, but it has very similar sequence and structure with hen egg white lysozyme.
















Fig. 6. Pairwise sequence similarity of all the 80 antigen
sequences.
To identify antibody-ignored epitope residues by our
method, we modified our computational process by
skipping the first three steps which are specially for iden-
tifying paratope associated candidate epitope residues.
From the F1-scores shown in Table 5, we can see that
our method is competitive to, sometimes much better
than the three structure based methods even though we
take only sequence information as input. In particular,
our method can provide much better results on identi-
fying epitope residues from those more completely ex-
plored antigen sequences. For example, we can correctly
identify 37 of the 55 epitope residues and include only
7 non-epitope residues as epitope residues from hen
egg white lysosyme, achieving an F1-score of 0.75. This
performance is much better than 0.68 by ElliPro, 0.52 by
DiscoTope, and 0.72 by SEPPA. All these demonstrate
that even without 3D structural information, the simpli-
fied version of ABepar for antibody-ignored prediction
is also powerful to identify epitope residues.
We once again stress the importance and complexity
of the antibody-specified epitope prediction problem.
We show some extreme pairwise dissimilarities between
different epitopes of an antigen. Taking hen egg white
lysozyme again, this antigen can interact with as many
as 44 different antibodies (some are mutants of the wild
type antibody, for instance 1G7H, 1G7I, 1G7J, 1G7L,
1G7M are mutants of 1VFB), and there are 55 antigenic
residues in total in the 129 residues of this antigen.
However, the average number of resides over these
antibody-specified epitopes is only 16.32.0. The aver-
age pairwise epitope similarity of these 44 epitopes is
0.359. More remarkably, 58.4% of these pairwise epitope
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Fig. 7. Reconfiguration of epitope when hen egg white
lysozyme interacts with different antibodies (PDB:1A2Y
and PDB:2IFF). Epitope residues in PDB:1A2Y are col-
ored by magenta while those epitope residues within
PDB:2IFF are colored by orange. All the rest residues are
rendered by cyan.
similarities are < 0.1, i.e. with less than 2 residues
in common between two epitopes. For example, the
epitope residues of PDB complex 1A2Y and 2IFF are
distributed on two entirely non-overlapping locations
on the surface of hen egg white lysozyme as shown
in Figure 7. Here the similarity between two epitopes
A and B is calculated by jATBj=(jAj  jBj), where
A
T
B represents the overlapping epitope residues, and
jXj means the residue number of X . These findings do
manifest the extreme reconfiguration of epitope when
an antigen binds to different antibodies. Therefore, it is
important to specify the corresponding antibody when
predicting epitope residues on a given antigen. We do
not mean that identifying epitope regardless of antibody
is less important, in fact we emphasize that identifying
an epitope with the specification of its antibody in some
applications is necessary as also stressed by [5].
4 DISCUSSION
In this study, the antibody-specified epitope prediction
problem is newly formulated. It is a more meaningful
but more challenging problem than the traditional epi-
tope prediction problem that does not consider antibody
information in the prediction. There are two main differ-
ences. First, antibody-antigen PDB complexes are used in
our model training, and antibody-antigen sequence pairs
without structure information are required for our model
testing. However, just antigen sequences or structures
without antibodies are needed for epitope identification
by the traditional epitope prediction models. Second, the
output of our model is a set of antigenic residues that
interact with the specific antibody excluding all other
antigenic residues that interact with other antibodies.
However, the output of the traditional model is a residue
union of all possible epitopes without any clarity to label
the constituent residues of any epitope.
Antibody-specified epitope prediction is first time
proposed by this work, hence there is no direct com-
parison between the new problem and the traditional
problem. Therefore a simplified version of our method
is introduced for a fair comparison, and it is tested
on a data set containing complexes which have been
relatively completely explored for epitopes. The purpose
of creating this data set is to avoid as much as possi-
ble the underestimation problem caused by incomplete
epitope exploration which has been argued by many
researchers [10], [11], [18]. The more complete epitope
exploration of one antigen is, the more convincing of the
result conducted on the data. Therefore hen egg white
lysozyme, whose epitopes are relatively completely ex-
plored, is taken as example to demonstrate the prediction
capability of different models.
In this study, we adopted a semi-supervised hidden
Markov model to complete the process of epitope predic-
tion. This approach can alleviate the wrong predictions
caused by the stringent cutoff thresholds of residues’
relative composition and cooperativity, and it also over-
comes the thorny problem raised by the imbalanced dis-
tribution of non-epitope residues and epitope residues.
The proposed antibody-specified epitope prediction
model is novel and promising, but it still surfers from the
scarce of training data set. Thus the leave-one-out cross
validation was used to evaluate this model. In every
iteration, one sample was left out for testing and the
remaining samples were taken for model construction.
Along with the increasing available samples, we believe
our model will show more powerful performance in
antibody-specified epitope prediction.
5 CONCLUSION
We summarize the whole work as follows. In this paper,
we have proposed a method called ABepar to pre-
dict antibody-specified epitopes with a high accuracy
and broad applicability. This method is trained on a
relatively small set of PDB complexes that contains
antibody-antigen structures, but it can be applied to
any antibody-antigen sequences without 3D structural
information. The novel idea of this method is based
on the context-awareness in the recognition between
paratope and epitope which is implemented by two
kinds of associations (preference and dependence). In
addition, the semi-supervised HMM also plays an im-
portant role in completing the process of epitope identi-
fication. It can capture the sequential relationship within
epitope residues at one hand, and also it overcomes
the insurmountable obstacles caused by the imbalance
distribution of the epitope and non-epitope residues
at the other hand. Furthermore, we also assessed the
performance of our model on epitope prediction when
antibody information is not given. The comparison re-
sults show that our sequence-based epitope prediction
method has a competitive performance compared with
structure-based prediction methods which have much
smaller applicability.
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